CIGARETTE-SMOKING AND THEOPHYLLINE METABOLISM - EFFECTS OF PHENYTOIN

被引:17
作者
CROWLEY, JJ
CUSACK, BJ
JUE, SG
KOUP, JR
VESTAL, RE
机构
[1] VET ADM MED CTR,RES SERV 151,CLIN PHARMACOL & GERONTOL RES UNIT,500 W FT ST,BOISE,ID 83702
[2] UNIV WASHINGTON HOSP,DEPT MED,SEATTLE,WA 98105
[3] UNIV WASHINGTON HOSP,DEPT PHARM PRACTICE,SEATTLE,WA 98105
关键词
D O I
10.1038/clpt.1987.157
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:334 / 340
页数:7
相关论文
共 32 条
[1]   EVALUATION OF A PROPOSED METHOD FOR PHENYTOIN MAINTENANCE DOSE PREDICTION FOLLOWING AN INTRAVENOUS LOADING DOSE [J].
CROWLEY, JJ ;
KOUP, JR ;
CUSACK, BJ ;
LUDDEN, TM ;
VESTAL, RE .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 32 (02) :141-148
[2]   THEOPHYLLINE KINETICS IN RELATION TO AGE - THE IMPORTANCE OF SMOKING [J].
CUSACK, B ;
KELLY, JG ;
LAVAN, J ;
NOEL, J ;
OMALLEY, K .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 10 (02) :109-114
[3]   CIGARETTE-SMOKING AND THEOPHYLLINE METABOLISM - EFFECTS OF CIMETIDINE [J].
CUSACK, BJ ;
DAWSON, GW ;
MERCER, GD ;
VESTAL, RE .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (03) :330-336
[4]  
Gibaldi M., 1984, BIOPHARMACEUTICS CLI, P17
[5]   CIGARETTE-SMOKING AND THEOPHYLLINE CLEARANCE AND METABOLISM [J].
GRYGIEL, JJ ;
BIRKETT, DJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (04) :491-496
[6]  
HUNT SN, 1976, CLIN PHARMACOL THER, V19, P546
[7]   DECREASED THEOPHYLLINE HALF-LIFE IN CIGARETTE SMOKERS [J].
JENNE, J ;
NAGASAWA, H ;
MCHUGH, R ;
MACDONALD, F ;
WYSE, E .
LIFE SCIENCES, 1975, 17 (02) :195-198
[8]   FACTORS AFFECTING THEOPHYLLINE CLEARANCES - AGE, TOBACCO, MARIHUANA, CIRRHOSIS, CONGESTIVE HEART-FAILURE, OBESITY, ORAL-CONTRACEPTIVES, BENZODIAZEPINES, BARBITURATES, AND ETHANOL [J].
JUSKO, WJ ;
GARDNER, MJ ;
MANGIONE, A ;
SCHENTAG, JJ ;
KOUP, JR ;
VANCE, JW .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (11) :1358-1366
[9]   ROLE OF TOBACCO SMOKING IN PHARMACOKINETICS [J].
JUSKO, WJ .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1978, 6 (01) :7-39
[10]  
JUSKO WJ, 1978, CLIN PHARMACOL THER, V24, P406